| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:400040434:1544 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:400040434:1544?format=raw |
LEADER: 01544pam a2200409 a 4500
001 4391505
005 20221102205241.0
008 020909t20032003enk b 001 0 eng
010 $a 2002034703
016 7 $a101171354$2DNLM
020 $a1843760509
020 $a9748840794
035 $a(OCoLC)ocm50178384
035 $a(NNC)4391505
035 $a4391505
040 $aDLC$cDLC$dYDX$dCOO$dNLM
042 $apcc
043 $aa-ja---$ae-uk---
050 00 $aRM301.25$b.H37 2003
060 00 $a2003 D-675
060 10 $aQV 744$bH254i 2003
082 00 $a615/.19/0941$221
100 1 $aHara, Takuji,$d1962-$0http://id.loc.gov/authorities/names/n2002111330
245 10 $aInnovation in the pharmaceutical industry :$bthe process of drug discovery and development /$cTakuji Hara.
260 $aCheltenham ;$aNorthhampton, MA :$bE. Elgar,$c[2003], ©2003.
300 $aix, 271 pages ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references (p. 208-260) and index.
650 0 $aDrug development$zJapan.
650 0 $aDrug development$zGreat Britain.
650 12 $aDrug Design.$0https://id.nlm.nih.gov/mesh/D015195
650 22 $aDrug Evaluation, Preclinical$xmethods.$0https://id.nlm.nih.gov/mesh/D004353Q000379
650 22 $aTechnology, Pharmaceutical.$0https://id.nlm.nih.gov/mesh/D013678
651 2 $aUnited Kingdom.$0https://id.nlm.nih.gov/mesh/D006113
651 2 $aJapan.$0https://id.nlm.nih.gov/mesh/D007564
852 00 $boff,hsl$hRM301.25$i.H37 2003